Literature DB >> 20635229

Relation of 99mTc-sestamibi washout with myocardial properties in patients with hypertrophic cardiomyopathy.

Satoshi Isobe1, Satoru Ohshima, Kazumasa Unno, Hideo Izawa, Katsuhiko Kato, Akiko Noda, Akihiro Hirashiki, Toyoaki Murohara.   

Abstract

BACKGROUND: We sought to determine the relationship between (99m)Tc-sestamibi washout and myocardial properties in hypertrophic cardiomyopathy (HCM) patients. METHODS AND
RESULTS: Twenty-four HCM patients underwent biventricular cardiac catheterization, with a micromanometer-tipped catheter, both at rest and during atrial pacing, echocardiography and myocardial (99m)Tc-sestamibi scintigraphy at rest. The (99m)Tc-sestamibi washout rate (WR) was calculated using initial and delayed planar images. The HCM patients were divided into two groups as follows: Group A consisted of 13 patients showing (99m)Tc-sestamibi WR < 22.5%; group B of 11 patients showing (99m)Tc-sestamibi WR ≥ 22.5%. Significant correlations were observed between (99m)Tc-sestamibi WR and percentage changes in pressure half-time (T (1/2)), as well as those in the maximum first derivative LV pressure (LV dP/dt (max)) (r = .43, P = .033; r = -.63, P = .001). The percentage changes in LV dP/dt (max) and those in T (1/2) were significantly more reduced in group B than in group A (P < .05). The biphasic force-frequency relation was more frequently observed in group B than in group A (82% vs. 18%).
CONCLUSION: Increased (99m)Tc-sestamibi washout is associated with an impaired contractile reserve and prolonged relaxation, suggesting that myocardial (99m)Tc-sestamibi scintigraphy may be useful in noninvasively detecting the early impairment of myocardial function in HCM patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20635229     DOI: 10.1007/s12350-010-9266-7

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  23 in total

1.  Biphasic changes in left ventricular end-diastolic pressure during dynamic exercise in patients with nonobstructive hypertrophic cardiomyopathy.

Authors:  Y Takeichi; M Yokota; M Iwase; H Izawa; T Nishizawa; R Ishiki; F Somura; K Nagata; S Isobe; A Noda
Journal:  J Am Coll Cardiol       Date:  2001-08       Impact factor: 24.094

2.  Impaired retention of technetium-99m tetrofosmin in hypertrophic cardiomyopathy.

Authors:  S Morishita; Y Kondo; M Nomura; H Miyajima; T Nada; S Ito; Y Nakaya
Journal:  Am J Cardiol       Date:  2001-03-15       Impact factor: 2.778

Review 3.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

4.  Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS.

Authors:  W L Henry; C E Clark; S E Epstein
Journal:  Circulation       Date:  1973-02       Impact factor: 29.690

5.  Isovolumic relaxation period in hypertrophic cardiomyopathy: assessment by radionuclide angiography.

Authors:  S Betocchi; R O Bonow; S L Bacharach; D R Rosing; B J Maron; M V Green
Journal:  J Am Coll Cardiol       Date:  1986-01       Impact factor: 24.094

6.  Hypertrophic cardiomyopathy: a discussion of nomenclature.

Authors:  B J Maron; S E Epstein
Journal:  Am J Cardiol       Date:  1979-06       Impact factor: 2.778

7.  Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells.

Authors:  A S Arbab; K Koizumi; K Toyama; T Arai; T Araki
Journal:  J Nucl Med       Date:  1998-02       Impact factor: 10.057

8.  Adrenergic control of the force-frequency and relaxation-frequency relations in patients with hypertrophic cardiomyopathy.

Authors:  H Izawa; M Yokota; Y Takeichi; M Inagaki; K Nagata; M Iwase; T Sobue
Journal:  Circulation       Date:  1997-11-04       Impact factor: 29.690

9.  Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.

Authors:  Franco Cecchi; Iacopo Olivotto; Roberto Gistri; Roberto Lorenzoni; Giampaolo Chiriatti; Paolo G Camici
Journal:  N Engl J Med       Date:  2003-09-11       Impact factor: 91.245

10.  Usefulness of Tc-99m methoxyisobutylisonitrile scintigraphy for evaluating congestive heart failure.

Authors:  Tomonori Sugiura; Hiroyuki Takase; Takayuki Toriyama; Takatoshi Goto; Ryuzo Ueda; Yasuaki Dohi
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

View more
  3 in total

1.  Left ventricular phase entropy: Novel prognostic predictor in patients with dilated cardiomyopathy and narrow QRS.

Authors:  Naoaki Kano; Takahiro Okumura; Satoshi Isobe; Akinori Sawamura; Naoki Watanabe; Kenji Fukaya; Hiroaki Mori; Ryota Morimoto; Katsuhiko Kato; Yasuko K Bando; Toyoaki Murohara
Journal:  J Nucl Cardiol       Date:  2017-02-07       Impact factor: 5.952

2.  A novel clinical indicator using cardiac technetium-99m sestamibi kinetics for evaluating cardiotoxicity in cancer patients treated with multiagent chemotherapy.

Authors:  Gian Piero Carboni
Journal:  Am J Cardiovasc Dis       Date:  2012-10-25

3.  (99m)Tc-MIBI Washout Rate to Evaluate the Effects of Steroid Therapy in Cardiac Sarcoidosis.

Authors:  Masayoshi Sarai; Sadako Motoyama; Yasuchika Kato; Hideki Kawai; Hajime Ito; Kayoko Takada; Ryuji Yoda; Hiroshi Toyama; Shin-Ichiro Morimoto; Yukio Ozaki
Journal:  Asia Ocean J Nucl Med Biol       Date:  2013
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.